Top Markets
Coin of the day
Biocure Technology Inc. Biocure Technology Inc.

Biocure Technology Inc.

CURE
Classifica tra le azioni #39915
Biocure Technology Inc., operating with its subsidiary, focuses on the creation... Biocure Technology Inc., operating with its subsidiary, focuses on the creation and market introduction of biopharmaceutical innovations, particularly those involving recombinant technologies and ranibizumab. The company's current development pipeline includes: Interferons-ß, aimed at treating multiple sclerosis. Ranibizumab, a monoclonal antibody fragment designed to address macular degeneration and a related eye condition known as macular edema. Filgrastim, which targets neutropenia – a deficiency of white blood cells that can arise from cancer, bone marrow transplants, chemotherapy, or other medical issues. Additionally, Biocure is conducting research and development into several promising areas: CAR T-cell therapy, which works by identifying and eradicating cancer cells. A vaccine against foot and mouth disease. Various products for promoting hair growth. The firm was established in 2005 and its corporate headquarters are located in Vancouver, Canada.
Prezzo delle azioni
$0.00366968
Ultima sincronizzazione: 2024-07-12
Capitalizzazione di mercato
$299.46K
Variazione (1 giorno)
-66.77%
Variazione (1 anno)
0.00%
Paese
CA
Scambia Biocure Technology Inc. (CURE)

Categoria

Storico del prezzo dell'azione per Biocure Technology Inc. (CURE)
Prezzo di chiusura più alto: $0.00 il 2024-07-01

Prezzo di chiusura più basso: $0.01 il 2009-03-01
Storico del prezzo dell'azione di Biocure Technology Inc. dal 2009 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2024 -66.52%
2023 45.61%
2022 -93.00%
2021 -11.53%
2020 -23.85%
2019 -54.33%
2018 42.23%
2017 3,176.92%
2016 2.72%
2015 68.45%
2014 -68.19%
2013 -16.07%
2012 -65.37%
2011 376.76%
2010 -26.05%
2009 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$517.18 32.51%
US
$857.76 31.47%
NL
$744.96 9.07%
CH
$1.07K -6.15%
KR
$259.89 14.81%
BE